SAB Biotherapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SABS and other ETFs, options, and stocks.

About SABS

SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company, which engages in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. The firm produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases. 

CEO
Samuel J. Reich
CEOSamuel J. Reich
Employees
63
Employees63
Headquarters
Miami Beach, Florida
HeadquartersMiami Beach, Florida
Founded
2014
Founded2014
Employees
63
Employees63

SABS Key Statistics

Market cap
20.61M
Market cap20.61M
Price-Earnings ratio
-0.50
Price-Earnings ratio-0.50
Dividend yield
Dividend yield
Average volume
294.04K
Average volume294.04K
High today
$2.04
High today$2.04
Low today
$1.94
Low today$1.94
Open price
$1.98
Open price$1.98
Volume
45.76K
Volume45.76K
52 Week high
$6.60
52 Week high$6.60
52 Week low
$1.00
52 Week low$1.00

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own SABS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.